MENU
CGON
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CG Oncology (CGON) Earnings Date & Reports

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer... Show more

A.I. Advisor
published Earnings

CGON is expected to report earnings to rise 4.35% to -47 cents per share on March 27

CG Oncology CGON Stock Earnings Reports
Q4'25
Est.
$-0.48
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.12
Q1'24
Missed
by $0.01
The last earnings report on March 28 showed earnings per share of -46 cents, missing the estimate of -44 cents. With 561.99K shares outstanding, the current market capitalization sits at 3.21B.
View a ticker or compare two or three
CGON
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGON showed earnings on March 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
61
Web
https://www.cgoncology.com